CS logo
small CS logo
Augusta Oncology Associates PC-D'Antignac

Augusta, Georgia, United States
Oncologist in Augusta, Georgia
1303 D'Antignac St # 1000, Augusta, GA 30901

About Augusta Oncology Associates PC-D'Antignac


"Augusta Oncology's Downtown location on D'Antignac Street is conveniently located in the Professional Office Building just across the street from University Hospital, with on-site parking. Our private practice offers the most comprehensive, compassionate cancer care and blood disorder treatment for Augusta, GA and surrounding areas. We also offer outpatient infusion treatments for various conditions."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
11
Alliance for Clinical Trials in Oncology
6
ECOG-ACRIN Cancer Research Group
1
SWOG Cancer Research Network
1
Total Rows: 4

Clinical Trials at Augusta Oncology Associates PC-D'Antignac


During the past decade, Augusta Oncology Associates PC-D'Antignac conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 4 clinical trials were completed, i.e. on average, 30.8% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1133220033222200000011110000Started TrialsCompleted Trails201520162017201820192020202101234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
2004-10-26
Active, not recruiting
452
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
2006-04-07
2030-09-30
Active, not recruiting
10,273
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
2013-04-01
2030-01-01
Active, not recruiting
1,900
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
2013-12-13
Active, not recruiting
1,473
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy
2015-04-29
2031-03-29
Active, not recruiting
415
Breast Cancer WEight Loss Study (BWEL Study)
2016-08-01
Active, not recruiting
3,177

Rows per page:

1–19 of 19

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Augusta Oncology Associates PC-D'Antignac" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator and "NRG Oncology" with 2 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 14 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 11National CancerInstitute (NCI): 11Alliance for ClinicalTrials in Oncology: 6Alliance for ClinicalTrials in Oncology: 6ECOG-ACRIN CancerResearch Group: 1ECOG-ACRIN CancerResearch Group: 1SWOG Cancer ResearchNetwork: 1SWOG Cancer ResearchNetwork: 1

Created with Highcharts 11.1.0Top CollaboratorsNational Cancer Institute (NCI): 8National Cancer Institute (NCI): 8Canadian Cancer Trials Group: 2Canadian Cancer Trials Group: 2Cancer and LeukemiaGroup B: 2Cancer and LeukemiaGroup B: 2NCIC Clinical Trials Group: 2NCIC Clinical Trials Group: 2NRG Oncology: 2NRG Oncology: 2North Central CancerTreatment Group: 2North Central CancerTreatment Group: 2SWOG Cancer ResearchNetwork: 2SWOG Cancer ResearchNetwork: 2American College ofSurgeons: 1American College ofSurgeons: 1Bayer: 1Bayer: 1Division of Cancer Control: 1Division of Cancer Control: 1

Clinical Trials Conditions at Augusta Oncology Associates PC-D'Antignac


According to Clinical.Site data, the most researched conditions in "Augusta Oncology Associates PC-D'Antignac" are "Invasive Breast Carcinoma" (3 trials), "Lynch Syndrome" (2 trials), "Stage II Breast Cancer" (2 trials), "Stage III Breast Cancer AJCC v7" (2 trials) and "Stage IIIA Breast Cancer" (2 trials). Many other conditions were trialed in "Augusta Oncology Associates PC-D'Antignac" in a lesser frequency.

Clinical Trials Intervention Types at Augusta Oncology Associates PC-D'Antignac


Most popular intervention types in "Augusta Oncology Associates PC-D'Antignac" are "Drug" (16 trials), "Other" (16 trials), "Biological" (8 trials), "Procedure" (6 trials) and "Radiation" (2 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (9 trials), "Questionnaire Administration" (7 trials), "Biospecimen Collection" (5 trials), "Laboratory Biomarker Analysis" (5 trials) and "Computed Tomography" (4 trials). Other intervention names were less common.

Clinical Trials Genders at Augusta Oncology Associates PC-D'Antignac


The vast majority of trials in "Augusta Oncology Associates PC-D'Antignac" are 15 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Augusta Oncology Associates PC-D'Antignac


Currently, there are NaN active trials in "Augusta Oncology Associates PC-D'Antignac". undefined are not yet recruiting, 5 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Augusta Oncology Associates PC-D'Antignac, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Augusta Oncology Associates PC-D'Antignac, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 18Phase 3: 18Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 13Active, not recruiting: 13Recruiting: 5Recruiting: 5Terminated: 1Terminated: 1